Obstetrics & Gynecology Doctors in Parkersburg, WV Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Dr. Patricia Susan Cabaniss, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 600 18th St, Suite 201, Parkersburg, WV 26101 Phone: 304-424-4751    Fax: 304-424-4753

Lisa A Casalenuovo, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 Garfield Ave Ste 200, Parkersburg, WV 26101 Phone: 304-424-2165    Fax: 304-424-2166

Eric Richard Lowden, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 705 Garfield Ave, Suite 420, Parkersburg, WV 26101 Phone: 304-424-2085    Fax: 304-424-2043

Mrs. Heather M Irvin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 604 Ann St, Parkersburg, WV 26101 Phone: 304-865-5065    Fax: 304-865-5036

Michael C Shockley, MD Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 705 Garfield Ave, Suite 400, Parkersburg, WV 26101 Phone: 304-485-4700    Fax: 304-485-4466

News Archive

Considerable amounts of cancer-causing chemicals gets absorbed by lungs during vaping

E-cigarettes have become increasingly popular as a smoke-free alternative to conventional tobacco cigarettes, but the health effects of "vaping" on humans have been debated in the scientific and tobacco manufacturing communities.

JAMA publishes Probuphine Phase 3 clinical trial data

Titan Pharmaceuticals, Inc. today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA).

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.

Fenwal's new Autopheresis-C software facilitates faster plasma-collection times

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that in a trial of its new Autopheresis-C® software, plasma-center professionals and donors reported faster plasma-collection times and an improved plasma-collection and donation experience. More than 90 percent of donors surveyed reported a decrease in their donation wait time. Donors who are more satisfied are more likely to donate regularly.

New study to explore how medical cannabis affects people with chronic pain

A team of researchers at the University of Georgia will study how legalized medical cannabis affects people living with chronic pain.

Read more Medical News

› Verified 6 days ago